Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension Todd M. KolbRachel L. DamicoPaul M. Hassoun CLINICAL IMPLICATIONS 07 July 2011 Pages: 729 - 732
Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a “one size fits all” approach? Xavier Clemente-CasaresSue TsaiPere Santamaria Review 16 April 2011 Pages: 733 - 742
Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development Sarah M. CorkErwin G. Van Meir Review 21 April 2011 Pages: 743 - 752
Animal models and molecular imaging tools to investigate lymph node metastases Elliot L. ServaisChristos ColovosPrasad S. Adusumilli Review 10 May 2011 Pages: 753 - 769
Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension Gopinath SutendraPeter DromparisEvangelos D. Michelakis Original Article 02 August 2011 Pages: 771 - 783
Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria Ewa Gurgul-ConveyIlir MehmetiSigurd Lenzen Original Article 13 April 2011 Pages: 785 - 798
The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y2-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation Mirjam SchuchardtJasmin PrüferMarkus Tölle Original Article 13 April 2011 Pages: 799 - 810
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II Guillem CasanovasDorine W. SwinkelsMartina U. Muckenthaler Original Article 08 April 2011 Pages: 811 - 816
Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma Lantu GouWei WangJinliang Yang Original Article 08 April 2011 Pages: 817 - 827